L-Amino acid deaminase (LAAD) is a key enzyme in the deamination of L-valine (L-val) to produce α- ketoisovalerate (KIV). However
the product inhibition of LAAD is a major hindrance to industrial KIV production. In the present study
a combination strategy of modification of flexible loop regions around the product binding site and the avoidance of dramatic change of main-chain dynamics was reported to reduce the product inhibition. The four mutant PM-LAAD
M4
(PM-LAAD
S98A/T105A/S106A/L341A
) achieved a 6.2-fold higher catalytic efficiency and an almost 6.7-fold reduction in product inhibition than the wild-type enzyme. Docking experiments suggested that weakened interactions between the product and enzyme
and the flexibility of the “lid” structure relieved LAAD product inhibition. Finally
the whole-cell biocatalyst PM-LAAD
M4
has been applied to KIV production
the titer and conversion rate of KIV from L-val were 98.5 g·L
-1
and 99.2% at a 3-L scale
respectively. These results demonstrate that the newly engineered catalyst can significantly reduce the product inhibition
that making KIV a prospective product by bio
conversion method
and also provide the understanding of the mechanism of the relieved product inhibition of PM-LAAD.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.